(Q46841769)

English

Homology modeling of wild-type, D516V, and H526L Mycobacterium tuberculosis RNA polymerase and their molecular docking study with inhibitors

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

25 December 2017

http://europepmc.org/abstract/MED/18092831

Homology modeling of wild-type, D516V, and H526L Mycobacterium tuberculosis RNA polymerase and their molecular docking study with inhibitors (English)

1 reference

Europe PubMed Central

25 December 2017

http://europepmc.org/abstract/MED/18092831

Mycobacterium tuberculosis

0 references

author name string

Daniela Josa

1

1 reference

Europe PubMed Central

25 December 2017

http://europepmc.org/abstract/MED/18092831

Elaine F F da Cunha

2

1 reference

Europe PubMed Central

25 December 2017

http://europepmc.org/abstract/MED/18092831

Teodorico C Ramalho

3

1 reference

Europe PubMed Central

25 December 2017

http://europepmc.org/abstract/MED/18092831

Thais C S Souza

4

1 reference

Europe PubMed Central

25 December 2017

http://europepmc.org/abstract/MED/18092831

Melissa S Caetano

5

1 reference

Europe PubMed Central

25 December 2017

http://europepmc.org/abstract/MED/18092831

publication date

1 February 2008

1 reference

Europe PubMed Central

25 December 2017

http://europepmc.org/abstract/MED/18092831

Journal of Biomolecular Structure and Dynamics

1 reference

Europe PubMed Central

25 December 2017

http://europepmc.org/abstract/MED/18092831

25

1 reference

Europe PubMed Central

25 December 2017

http://europepmc.org/abstract/MED/18092831

4

1 reference

Europe PubMed Central

25 December 2017

http://europepmc.org/abstract/MED/18092831

373-376

1 reference

Europe PubMed Central

25 December 2017

http://europepmc.org/abstract/MED/18092831

Structural mechanism for rifampicin inhibition of bacterial rna polymerase

1 reference

https://api.crossref.org/works/10.1080%2F07391102.2008.10507185

21 January 2018

Frequency of rpoB mutations inside and outside the cluster I region in rifampin-resistant clinical Mycobacterium tuberculosis isolates

1 reference

https://api.crossref.org/works/10.1080%2F07391102.2008.10507185

21 January 2018

The magic bullets and tuberculosis drug targets.

1 reference

https://api.crossref.org/works/10.1080%2F07391102.2008.10507185

21 January 2018

Comparison of antibacterial and antiimmune effects of certain rifamycins

1 reference

https://api.crossref.org/works/10.1080%2F07391102.2008.10507185

21 January 2018

In vitro antimycobacterial activities of newly synthesized benzoxazinorifamycins

1 reference

https://api.crossref.org/works/10.1080%2F07391102.2008.10507185

21 January 2018

ProMod and Swiss-Model: Internet-based tools for automated comparative protein modelling

1 reference

https://api.crossref.org/works/10.1080%2F07391102.2008.10507185

21 January 2018

Large-scale protein modelling and integration with the SWISS-PROT and SWISS-2DPAGE databases: the example of Escherichia coli.

1 reference

https://api.crossref.org/works/10.1080%2F07391102.2008.10507185

21 January 2018

SWISS-MODEL: An automated protein homology-modeling server

1 reference

https://api.crossref.org/works/10.1080%2F07391102.2008.10507185

21 January 2018

The Protein Data Bank

1 reference

https://api.crossref.org/works/10.1080%2F07391102.2008.10507185

21 January 2018

Allosteric modulation of the RNA polymerase catalytic reaction is an essential component of transcription control by rifamycins

1 reference

https://api.crossref.org/works/10.1080%2F07391102.2008.10507185

21 January 2018

WHAT IF: a molecular modeling and drug design program

1 reference

https://api.crossref.org/works/10.1080%2F07391102.2008.10507185

21 January 2018

MolDock: a new technique for high-accuracy molecular docking

1 reference

https://api.crossref.org/works/10.1080%2F07391102.2008.10507185

21 January 2018

Pseudo-peptides derived from isomannide as potential inhibitors of serine proteases.

1 reference

https://api.crossref.org/works/10.1080%2F07391102.2008.10507185

21 January 2018

N- t-Boc-amino acid esters of isomannide. Potential inhibitors of serine proteases

1 reference

https://api.crossref.org/works/10.1080%2F07391102.2008.10507185

21 January 2018

Errors in protein structures

1 reference

https://api.crossref.org/works/10.1080%2F07391102.2008.10507185

21 January 2018

Interactions of 5-deazapteridine derivatives with Mycobacterium tuberculosis and with human dihydrofolate reductases

1 reference

https://api.crossref.org/works/10.1080%2F07391102.2008.10507185

21 January 2018

Protein Modeling by E-mail

1 reference

https://api.crossref.org/works/10.1080%2F07391102.2008.10507185

21 January 2018

The search for new DHFR inhibitors: a review of patents, January 2001 – February 2005

1 reference

https://api.crossref.org/works/10.1080%2F07391102.2008.10507185

21 January 2018

Computer-Assisted Analysis of the Interactions of Macrocyclic Inhibitors with wild Type and Mutant D168A Hepatitis C Virus NS3 Serine Protease

1 reference

https://api.crossref.org/works/10.1080%2F07391102.2008.10507185

21 January 2018

Influence of nonbonded interactions in the kinetics of formation of chalcogenol esters from chalcogenoacetylenes

1 reference

https://api.crossref.org/works/10.1080%2F07391102.2008.10507185

21 January 2018

Identifiers

10.1080/07391102.2008.10507185

1 reference

Europe PubMed Central

25 December 2017

http://europepmc.org/abstract/MED/18092831

1 reference

Europe PubMed Central

25 December 2017

http://europepmc.org/abstract/MED/18092831

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q46841769&oldid=2139359420"